Interview with Dreamit Venture’s Adam Dakin: “Sophisticated investors will focus in on the QMS”

Posted on: July 7, 2020

Cannon Quality Group recently had the opportunity to sit down to talk shop with Adam Dakin, Managing Director of the Healthtech segment at Philadelphia-based Dreamit Ventures. We were interested in Dreamit-backed companies (some of which are also CQG clients), Dreamit’s approach to investing in and building healthtech companies, and the role of quality management is assessing the viability of medtech startups.

Adam Dakin has started five companies, was CEO of three, and has raised money for all startups in which he’s been involved. He’s served as a board member, angel investor, advisor, and teaches a class at the University of Pennsylvania on how to take ideas from the lab all the way to commercialization. Dakin is also a mentor in residence at the Penn Center for Innovation.

“About 2 and a half years ago, Dreamit came along and said we’re looking for someone to run our healthtech vertical, which was kind of the dream job for me because I get to be both an operator and an investor. I knew that I probably always wanted at some point to move over to the venture side, but this was a nice opportunity to keep one foot in each world.”

The Dreamit Difference

“We are different from a traditional venture fund,” Adam explained, “even though our returns model is based on being a traditional venture fund. What’s different is that we run what some might call an accelerator, although we prefer to call it a growth platform. I like to call us the ‘sleeves-up’ venture fund because we run this growth program alongside of our venture fund and our fund only invests in companies that have gone through that growth platform. It’s different from what you might think of as a traditional incubator/accelerator because our companies are later stage. On the digital health side, our companies are in market, they have referenceable customers, are generating revenue, they’ve already raised capital, and it’s all about scaling the business. And leveraging our stakeholder network, which includes payors, providers, and large multinationals, where we have red carpet access to decision makers in those organizations which greatly accelerates the sales cycle.”

“That’s how we add value” Dakin says. “We do the same thing with access to our investor network – we reach out to over a 1000 venture funds who know how carefully selected our cohorts are. We run 2 cohorts a year; there are typically 6-8 companies in the healthtech and securetech verticals; For healthtech, it’s medical devices, diagnostics, and digital health. These companies are all typically raising their first large round of institutional capital, and they are raising in order to scale. It’s important for our model that we help them raise that institutional capital, because we need to create the opportunity for us to co-invest alongside the institutional investor. We’re not getting a huge chunk of equity upfront for the program; we get our returns by investing after the program. We don’t take board seats, we don’t lead deals, we don’t set terms; we just work like mad to find a lead investor for them, so we get that opportunity to co-invest. Our not-so-secret sauce is that we get to know these companies really well during the 14-week program which informs our investment decisions.”

“We are in regular communication throughout the week; we’re deep diving into every critical assumption behind their business model; we’re tearing all the key assumptions apart; and making sure that everything is tight because with our operating experience we bring a lot of pattern recognition; we know what customers are going to ask, we know what investors are going to ask, so we’re pretty good at surfacing the soft spots and making them do the work to tighten up those weaknesses. So by the time we put them in front of customers or investors, they’re bullet proof. They are extremely well prepared. We get positive feedback from customers and investors all the time when they say ‘wow – I can tell that’s a Dreamit company, that pitch was tight. We covered what we needed them to cover, they were super-efficient, the value prop and problem statement was crystal clear – we get it!’ “.

Common Pitfalls in the Pitching Process

We were curious to know what mistakes he sees entrepreneurs often make during the pitching process.

“It is frequently on attitude and style” Dakin said. Some are overconfident, not acknowledging some of the critical risks and how challenging it will be to overcome those risks. He might ask about clinical risk, for example, and hear something like “oh, no problem – we’re going to run some clinicals…” but a button-downed, crisp plan has not been developed. The Dreamit team will ask details on statistical significance, sample size, how much it is going to cost, who the principal investigators will be, and other aspects.

If it’s regulatory risk, Dakin will ask how they plan to navigate and mitigate that risk, and have they really understand the requirements. Some founders minimize risks, citing predicate devices, but Dreamit wants to know what testing will take place, what data will be collected, what claims the company plans to make, and if they have had a pre-sub meeting with the FDA.

“Sometimes we hear ‘I met with a regulatory consultant, and they thought we were fine’ but we’re not going to take your consultant’s response at face value,” Dakin said.

In digital health, Dreamit looks carefully at the critical nature of go-to-market strategies. Often, applicants haven’t thought through who the customer is, who the decision makers are, the stakeholders, how to reach those customers, and call points. They are sometimes fuzzy on pricing – is it transactional, is it SaaS, or some variation?

“Just saying ‘we’re going to hire some reps..’ is not a go to market strategy” Dakin said. “That’s a sales tactic. I want you to tell us very specifically where your first $1m of sales is coming from – is it 10 customers at $100k? How are you going to attract those 10 customers, how will you reach them? Companies fall down when you pressure-test their go to market strategy.”

Investors Evaluate the Quality Management System

Do investors consider the robustness or appropriateness of the company’s Quality Management System?

“Sophisticated investors will focus in on the QMS assuming the device or platform is regulated”, Dakin said, “and it’s one of those things that you can ask entrepreneurs – how familiar they are with QMS, do they understand, are they planning for that in the beginning of the process because to go back later forensically and put in a QMS is just a bad idea. A venture buddy of mine says ‘There’s never time to do it right but there’s always time to do it over.’ Doing QMS-lite in the beginning is just fine. You don’t want to encumber a startup or small company with ridiculous requirements but you want to make sure as they move along that they don’t have to go back and re-do a lot of things, when for a small amount of effort in the beginning they could have put those underpinnings in place and just made life so much easier.”

“Some companies will say, ‘well we’re not regulated, we don’t need to worry about a QMS’ and that may or may not be right at that moment, but if you want to expand your claims later on to make an efficacy or diagnostic claim, that’s when you may cross over to being regulated. At which point you will have to have a QMS. So it’s skating to where the puck is going to be if you think about your business in the future. “

Some say they want to stay on the unregulated side at first to prove some level of market acceptance. But the forward-looking companies know that’s just the beginning of the go-to-market strategy, and later they may want to make a claim around safety and efficacy and go to the FDA. “And if that’s the moment we decide to put a QMS in place,” Dakin says, “It’s going to be a lot of work.”

Other bits of wisdom: it always takes longer and costs more than you think it will to build the company and get to market. Startups, he believes, should always raise more than they think they need, and always take money when offered. “Later, if you need it, it will be the cheapest money you ever raised.”
Some CEOs see their role as being focused on building a great team and a great product. “But the top priority answer is to keep the company well capitalized.”

“Everybody wants pedigreed entrepreneurs out of central casting, but we look for coachability.” Dakin says. “That reveals itself in the due diligence process. When a founder appears to be uncoachable, that’s a show stopper.”

About Us: Cannon Quality Group provides outsourced Quality Management System solutions that are efficient and compliant. Cannon’s number one priority is delivering QMS solutions that make sense for the stage and goals of its clients’ business. Cannon Quality Group’s mission is to be the Change in Quality.


"It has been almost a year since your mentorship for SDIP Innovations since we were chosen as 2020 Rosenman Innovators. I wanted to say a big fat THANK YOU for your fundamental contribution to SDIP`s progress. Your Insights and expert opinions have been absolutely game-changer for me and SDIP. You…"

-Maryam Parviz/MSc, Ph.D, Co-founder and Chief Executive Officer, SDIP Innovations

"The shared audit program allows us to meet the needs of our supplier auditing procedure without having to schedule individual site audits; this saves us time and resources while enabling us to maintain compliance with the requirements of our quality management system."

-Scott Sershen/BlackSwan Vascular, Inc. Hayward, CA

"I am working on aging and packaging which they specifically said was assigned based on my experience at Cannon. Your internship program is literally the gift that keeps on giving."

-Maggie Baker/R&D engineer intern, former CQG intern from California Polytechnic State University, San Luis Obispo, CA, now at a major medical device manufacturer.

"I just wanted to drop a quick note to thank you all for your support over these past several months. We had a very successful audit this week. Both auditors were very complimentary of the progress we have made since the last audit and that is really a testament to…"

-Zachary Woodson/Vice President of Regulatory Affairs & Quality, LimFlow SA, Santa Clara, CA and Paris, France

"Look what you have done!  Profusa has a functional QS thanks in large part to you. The GMED auditor has conducted over 700 audits and said we have an extremely good QS and a lot of that credit goes to you… I just wanted to let you know that Profusa…"

-David Hesting/QA Director, Profusa, Inc., Emeryville, CA

"My Manager reviewed and approved this validation, and he called me to say it would be the gold standard for spreadsheet validations for all Nordson Medical D&D sites from this point forward!"

-Kim Trottier/Quality Information Systems Manager, Nordson Medical, Marlborough, MA

"Our notified body commented that he was impressed with the focus and professionalism of the Emboline team during a recent audit. This is largely a credit to the Cannon Quality Group team. Your team, as always, was extremely organized, well-prepared and professional. Thank you!"

-Scott Russell/President and CEO at Emboline, Inc., Los Altos, CA

"Everything about the audit process including scheduling, the audit itself, and results & follow-up were seamless and enabled LamaMed Solutions, Inc. to fulfill its requirements for Internal Audit and assessment of QMS conformance with ISO 13485:2016 in advance of our Notified Body audit."

-Lloyd Griese/Quality and Regulatory Consultant, LamaMed Solutions, Inc., Hayward, CA

"Our SVP of QA/RA performs mock-FDA audits across all our global facilities. So it was huge compliment for us when, after reviewing all aspects of a software validation authored by Cannon Quality Group, he said it was as good a validation as he had ever seen."

-Ron Koronkowski/Director of Quality & Regulatory, Vention Medical, Inc., Sunnyvale, CA

"Cannon Quality Group's staff was highly engaged and responsive to our needs. They were easy to work with and provided a high-quality work product."

-Caroline Jewett/Consultant for PvP Biotech, Seattle, WA

"It was by far the best QSR/GMP training – high caliber content and engaging delivery."

-Robert Angelopoulos/Sr. Engineering Manager, Powervision, Inc., San Mateo, CA

"Don’t stress. Call Cannon Quality Group for great project support."

-David Freed/Sr. Quality Director, AcelRx Pharmaceuticals, Inc., Redwood City, CA

"My 3rd party ISO 13485:2016 audit was extremely beneficial to my company. The auditor was very knowledgeable about the standard and current trends that notified bodies are looking for."

-Tom Mason/Director QA, Vactronix Scientific, Fremont, CA

"When strategic partners were doing due diligence, I think they expected to find an empty drawer where the Quality Management System would be. We started showing them the procedures and design files that Cannon Quality Group helped us establish, and they were pleasantly surprised to get just what they wanted…The ability of…"

-Don Bogue/President/CEO, Compact Imaging, Mountain View, CA

"Our [CQG] auditor provided findings with value-based explanations and implementation ideas."

-Kyle Dion/Quality Specialist, BlueLine Sterilization Services, Novato, CA

"CQG has been with my organization from the nascent stages of our QMS.  Their team of experts coached us on the ISO standards, provided training classes, furnished sample QMS documentation, and were always quick to respond to our endless questions.  Most importantly they were present at our crucial certification and customer audits. …"

-Kathleen Perry/Twist Biosciences, San Francisco, CA

"Working with Cannon was a pleasure. They helped us create our first formalized Quality Management System with just the right balance of rigor, detail-orientation, and practicality. I would definitely work with Cannon again in the future on quality management projects."

-Gideon Wald/CTO Welkin Health, San Francisco, CA

"JenaValve would like to extend a very appreciated “Thank You” to the whole Cannon Group team in supporting us, JenaValve, through the quality system improvements and associated activities. Your organization has been exceptional in supporting the chaotic schedule and the Cannon Group team members have performed above and beyond the…"

-Peter Wulff/CFO JenaValve, Irvine, CA, Leeds, U.K. and Munich, Germany

"Your team is great, love the maturity level. Great respect from Quality & Regulatory."

-Mark Adler/Senior Director of R&D JenaValve, Irvine, CA, Leeds, U.K. and Munich, Germany

"CQG has really shattered my preconceptions of what contracted support can do for a quality system. They are true professionals from the advice they provide, work they produce, and the integrity of actions. From complicated design control issues, to Process Validation, to Doc Control, they have been a huge resource…"

-David Hesting/QA Director, Profusa, Inc., Emeryville, CA

"Amy has done an amazing job here and we appreciate all her help. Communication with everyone/doc control is good/responsive, and we especially appreciate the quick turnaround on hot DCO’s – they find everything."

-Bijesh Chandran/VP of Quality, R2 Dermatology, San Ramon, CA

"Cannon Quality Group is an absolute pleasure. For our startup, CQG made QSR development and compliance enjoyable and easy. Their unique style and system has allowed us to work at the fast pace required by the market, while still maintaining regulatory compliance."

-Andrew Hosford/Director of Engineering, Gauss Surgical, Menlo Park, CA

"Our startup was working with a skeleton quality system and struggling to apply QSR standards, when we brought in the Cannon Quality Group. They overhauled and sharpened our quality system so that it complied with the QSR, in only a few months, which allowed us to have a flawless audit.…"

-CQG client/

"When a key employee quit just as the load on my QA group exploded because of a clinical build, CQG stepped in immediately with the resources we needed to keep us going. I hope nothing like this ever happens to us again but, if it does, I’ll know exactly whom…"

-Ari Zak/Sr. VP, Clinical, Regulatory & Quality and Corporate Counsel, PowerVision, San Mateo, CA

"Prior to CQG, our startup worked with another company which made quality slow, very expensive, and highly frustrating. Comparatively, CQG has been a game changer for our company. They have made QSR development and compliance enjoyable and easy, which has allowed us to work at the fast pace required by…"

-CQG Client/

"Kudos to the Cannon Quality Group for helping us get through our FDA audit with zero 483s and just a few CAPAs.Their expertise in quickly turning our bare bones QMS into a robust system is exactly what was needed."

-Shaun R. Bagai/CEO – RenovoRx, Inc., Los Altos, CA

"Pete is awesome, I appreciate the help he provides to our team and his assistance in various quality needs."

-Kityee Au-Yeung/Profusa, Emeryville, CA

"As a new Quality Director at a young start-up company, I am happy to leave a recommendation for Cannon Quality Group. Cannon Quality Group has an innovative and efficient process in place to bring a working Quality System to a start-up company in a short amount of time. Cannon retains…"

-Delane Dale/Quality Director – BioInspire Technologies, Palo Alto, CA
/* */